Torsade de pointes

	Torsades de pointes Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Torsades de pointes from other Diseases
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
EKG Examples
Echocardiography
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Torsade de pointes On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Torsade de pointes All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Torsade de pointes
CDC on Torsade de pointes
Torsade de pointes in the news
Blogs on Torsade de pointes
Directions to Hospitals Treating Torsades de pointes
Risk calculators and risk factors for Torsade de pointes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Drugs: quinidine, PCA, norpace, amiodarone, phenothiazines, Tricyclic antidepressants, pentamidine.
- with quinidine majority of the cases occur within one week of initiation, and with therapeutic levels
Electrolyte imbalances: Hypokalemia, hypomagnesemia, hypocalcemia
CAD
MVP
Variant angina
Myocarditis
Subarachnoid hemorrhage
Congenital QT prolongation
Liquid protein diets
Hypothyroidism
- because of bradycardia and a prolonged QT syndrome
Organophosphate poisoning ^[1] ^[2]

Other lab studies

↑ Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.
↑ Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016